The Veterinary Record Link to Vetlife website
HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
 QUICK SEARCH:   [advanced]


     


Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKellar, Q.
Right arrow Articles by Lees, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKellar, Q.
Right arrow Articles by Lees, P
The Veterinary Record, Vol 124, Issue 25, 651-654
Copyright © 1989 by British Veterinary Association


Papers & Articles

Flunixin pharmacokinetics and serum thromboxane inhibition in the dog

QA McKellar, EA Galbraith, JA Bogan, CS Russell, RE Hooke, and P Lees

Department of Veterinary Pharmacology, University of Glasgow Veterinary School.

Flunixin meglumine administered orally to beagle dogs at doses of 0.55, 1.10 or 1.65 mg/kg bodyweight was rapidly absorbed to produce maximum mean plasma concentrations of 2.40 +/- 0.70, 4.57 +/- 1.12 and 7.42 +/- 2.07 micrograms/ml, respectively. Thereafter, the plasma concentrations of flunixin fell rapidly to values less than 0.10 micrograms/ml from 24 hours after drug administration at all dosage levels. The maximum mean inhibition of serum thromboxane B2 was 91.5 per cent after the lowest dose of flunixin and 98.8 per cent for both the intermediate and high dose rates. At plasma concentrations of flunixin above 2 micrograms/ml there was more than 90 per cent inhibition of thromboxane.





HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
Copyright © 1989 British Veterinary Association